Aerosolised Antibacterials for the Prevention and Treatment of Hospital-Acquired Pneumonia

Author： Wood G. Christopher   Swanson Joseph M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.6, 2007-01, pp. : 903-914

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy for hospital-acquired pneumonia

By Liapikou Adamantia   Rosales-Mayor Edmundo   Torres Antonio  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 775-786

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia

By Lagacé-Wiens Philippe RS  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 789-799

Informa Healthcare

Access to resources Recommend Favorite

Telavancin ATTAINs benefit in hospital-acquired pneumonia

By  

Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care

By Koulenti Despoina   Rello Jordi  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1555-1569

Informa Healthcare

Access to resources Recommend Favorite

Hospital acquired pneumonia

By Lim Wei Shen   Macfarlane John T  

Clinical Medicine, Vol. 1, Iss. 3, 2001-05 ,pp. : 180-184

Royal College Of Physicians

Access to resources Recommend Favorite